(Q34591297)

3 August 2017

1 reference

title

Nitric oxide in hypertension (English)

1 reference

3 August 2017

1 reference

3

Thomas F Lüscher

1 reference

3 August 2017

Matthias Hermann

1

1 reference

3 August 2017

Andreas Flammer

series ordinal

2

1 reference

3 August 2017

publication date

1 December 2006

1 reference

Journal of Clinical Hypertension

3 August 2017

published in

1 reference

3 August 2017

volume

8

1 reference

3 August 2017

issue

12 Suppl 4

1 reference

3 August 2017

page(s)

17-29

1 reference

Global burden of hypertension: analysis of worldwide data

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.06032.X

Prognostic significance of endothelial dysfunction in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.06032.X

Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.06032.X

Cardiac weight in hypertension induced by nitric oxide synthase blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.06032.X

Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 in clinically healthy smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.06032.X

Role of basal and stimulated release of nitric oxide in the regulation of radial artery caliber in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.06032.X

Treatment with tetrahydrobiopterin reduces blood pressure in male SHR by reducing testosterone synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.06032.X

Tetrahydrobiopterin restores endothelial dysfunction induced by an oral glucose challenge in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.06032.X

Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.06032.X

Quinaprilat Induces Arterial Vasodilation Mediated by Nitric Oxide in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.06032.X

Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.06032.X

Nitric oxide and its putative role in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.06032.X

Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.06032.X

Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.06032.X

Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.06032.X

Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.06032.X

Impact of aortic stiffness on survival in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.06032.X

Role of nitric oxide in the regulation of the mechanical properties of peripheral conduit arteries in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.06032.X

Increased activation of sympathetic nervous system and endothelin by mental stress in normotensive offspring of hypertensive parents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.06032.X

Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.06032.X

The sympathetic nervous system is involved in the maintenance but not initiation of the hypertension induced by N(omega)-nitro-L-arginine methyl ester.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.06032.X

Sympathetically mediated hypertension caused by chronic inhibition of nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.06032.X

NG-methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo. A role for nitric oxide in the central regulation of sympathetic tone?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.06032.X

Cardiovascular and sympathetic effects of nitric oxide inhibition at rest and during static exercise in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.06032.X

Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.06032.X

Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

21 January 2018

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1001/JAMA.290.2.199

Identifiers

DOI

10.1111/J.1524-6175.2006.06032.X

1 reference

3 August 2017

1 reference